American Headache Society Releases Position Statement on Novel Preventive and Acute Migraine TreatmentsJanuary 09, 2019
The American Headache Society has issued updated guidelines on the use of novel preventive and acute treatments for migraine in adults.
Vitamin D3 may reduce migraine days in patients who experience frequent migraines.
Cluster headache and migraine are distinct primary headache disorders that are associated with substantial pain and disability.
Migraine with aura is associated with an elevated risk for incident atrial fibrillation.
Eighty-five percent of patients report partial or complete resolution of headaches postoperatively.
Researchers and pain experts formulated guidelines for the use of onabotulinumtoxinA for the management of chronic migraine.
Recent high-quality clinical trial evidence has demonstrated that medications commonly prescribed for migraine prevention in pediatric patients were not superior to placebo for reducing headache symptoms.
A 32-year-old woman presents to the emergency department with gradually worsening generalized headache 8 days after giving birth to her second child.
Only 44 of parents would definitely go to ER if their child had headache that didn't improve with medication.
Investigators examined rates, predictors, and outcomes of neuroimaging in pediatric and adolescent patients who presented to the ED with a headache.
Oral medication, botulinum toxin type A injections, and endoscopic decompression surgery were all compared in the treatment of patients with frontal secondary headaches due to STN and SON configuration.
It is important for clinicians to quickly and accurately determine potential underlying causes and to prescribe treatments that take into account comorbidities and medications that older patients may be taking for them.
Although ischemic strokes are still very rare in children, 46% of pediatric ischemic stroke patients over 3 years of age said they had a headache before the stroke.
Dysfunction of the endocrine system may lead to various neurologic manifestations, including headaches.
Researchers examined a possible link between vitamin D, riboflavin, coenzyme Q10, and chronic migraines.
For patients with basilar or hemiplegic migraines, two common migraine medications do not increase the risk of stroke and cardiovascular events.
Headache is one of the most common complaints in outpatient practice. There are 10 things that clinicians need to know to help treat their patients with headache.
A nurse practitioner asks about a 21-year-old man who reports that his family is telling him that he is forgetful.
Patients with headaches should be counseled about making lifestyle changes before being referred to specialists.
Approximately 23% of adults and 5% to 10% of children complain of treatment-resistant chronic recurring headaches.
Administering the herpes zoster and pneumococcal vaccines to patients during the same visit does not appear to compromise the effectiveness of the zoster vaccine.
Incidence of severe cardiovascular events and death similar among children and teens that use ADHD medications and those who do not, study finds.
What can be done for a young patient who chooses oral contraception yet suffers severe headaches while on the Pill?
Physicians fail to follow the clinic's rules, which appear unrealistic in retrospect, regarding PA supervision.
A college student with a history of Bell's palsy and Henoch-Schönlein is concerned about new-onset headaches.
Warmer weather may mean more complaints of headaches from patients.
Feverfew is a medicinal herb that has largely been found safe and effective for migraine prophylaxis.
A systematic review of seven randomized placebo-controlled trials evaluated the...